We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+37.99%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
AUM
$1.36B
AUM Growth
+$289M
Cap. Flow
+$9.14M
Cap. Flow %
0.67%
Top 10 Hldgs %
37.58%
Holding
88
New
23
Increased
16
Reduced
17
Closed
24

Sector Composition

Rank Sector Weight
1 Technology 22.74%
2 Financials 16.37%
3 Healthcare 10.17%
4 Industrials 9.5%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXMD icon
51
TherapeuticsMD
TXMD
$24.1M
$5.47M 0.4%
90,412
-188,239
-68% -$12.9M
KDNY
52
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$5.17M 0.38%
325,863
-1
-0% -$15
BPOP icon
53
Popular Inc
BPOP
$11.2B
$5.09M 0.37%
+90,432
New +$4.29M
FUBO icon
54
PUT
FuboTV Inc
FUBO
$293M
$4.06M 0.3%
+12,092
New +$3.31M
MORF
55
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$3.96M 0.29%
117,970
+14,482
+14% +$428K
LORL
56
DELISTED
Loral Space and Communications, Inc.
LORL
$3.82M 0.28%
182,072
VIAO
57
DELISTED
VIA optronics AG American Depositary Shares, each representing one-fifth of an Ordinary Share
VIAO
$3.39M 0.25%
251,855
+76,855
+44% +$823K
SCTL
58
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$3.07M 0.23%
1,076,587
FBP icon
59
First Bancorp
FBP
$4.46B
$2.62M 0.19%
+284,436
New +$2.17M
ATNM icon
60
Actinium Pharmaceuticals
ATNM
$25.8M
$2.3M 0.17%
294,683
+237,165
+412% +$2.58M
CTEV
61
Claritev Corp
CTEV
$599M
$1.85M 0.14%
+5,775
New +$1.92M
OSG
62
Octave Specialty Group
OSG
$210M
$568K 0.04%
36,961
-316,511
-90% -$4.66M
BMY.RT
63
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$495K 0.04%
1,650,000
-716,965
-30% -$1.53M
KOP icon
64
Koppers
KOP
$857M
$470K 0.03%
+15,068
New +$392K
ASRT
65
DELISTED
Assertio
ASRT
-57,527
Closed -$2.3M
CVS icon
66
CVS Health
CVS
$121B
-425,770
Closed -$24.9M
GCO icon
67
Genesco
GCO
$391M
-214,007
Closed -$4.61M
GM icon
68
General Motors
GM
$76.1B
-500,000
Closed -$14.8M
IMMR icon
69
Immersion
IMMR
$247M
-557,259
Closed -$3.93M
INSM icon
70
Insmed
INSM
$28.9B
-1,100,000
Closed -$35.4M
IPHA
71
Innate Pharma
IPHA
$232M
-250,000
Closed -$960K
OPLN
72
Openlane
OPLN
$4.34B
-1,206,959
Closed -$17.4M
KBR icon
73
KBR
KBR
$4.8B
-619,250
Closed -$13.8M
KEX icon
74
Kirby Corp
KEX
$7.18B
-250,000
Closed -$9.04M
MD icon
75
Pediatrix Medical
MD
$2.15B
-560,857
Closed -$9.13M

Similar funds

Rubric Capital Management (New York)'s Q4 2020 Portfolio in Review

As of Q4 2020, Rubric Capital Management (New York) held 88 positions worth $1.36B, up 27% from $1.07B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Rubric Capital Management (New York)'s Q4 2020 filing shows 23 new, 16 increased, 17 reduced and 24 closed positions. Its largest new stake was Bunge Global: 700,000 shares worth $45.9M. The largest sale was Insmed, an estimated $35.4M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Rubric Capital Management (New York)'s largest Q4 2020 buy was Bunge Global: 700,000 shares worth $45.9M.
  • Rubric Capital Management (New York) added most to Adeia in Q4 2020, an estimated $17.2M increase.
  • Rubric Capital Management (New York)'s biggest Q4 2020 reduction was Avaya Holdings Corp. Common Stock, cutting an estimated $19.9M.
  • Rubric Capital Management (New York) fully exited Insmed in Q4 2020, selling an estimated $35.4M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 38% of its $1.36B portfolio in Q4 2020.
  • Rubric Capital Management (New York) opened 23 new positions and closed 24 in Q4 2020.
  • Rubric Capital Management (New York)'s portfolio value rose 27% quarter-over-quarter to $1.36B.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2020, filed 16 Feb 2021.